BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation is expanding its suite of patient-centric apps for improved clinical research. PHT announced the availability of the Patient Connect™ Engagement Suite of apps, an integrated set of patient tools now available as part of the PHT electronic clinical outcome assessment (eCOA) System. Pharmaceutical companies and CROs have leveraged the PHT eCOA System in 750+ trials resulting in over 21 regulatory approvals.
Watch a brief demo of the Patient Connect Engagement Suite: http://bit.ly/PHTPatientConnect
75% of 400 leading pharmas and CROs surveyed by eyeforpharma.com cited the “patient” as an organizational priority in 2015. The cost to recruit and enroll patients and dropout rates continue to rise. The Patient Connect Suite helps increase protocol compliance and prevent patient dropouts by improving the patients experience in clinical research. Participation in a study is easier, more engaging and more convenient with this educational and supportive app that can include SMS messaging and access to the patient’s own study data via the StudyWorks™ Patient Portal. Valuable features and communications tools include:
- Trial-specific FAQs, visit guides, instruction manuals and training
- Secure Patient Portal to review data provided and progress dashboard
- Survey tool for collecting feedback, etc.
Sheila Rocchio MBA, PHT Vice President of Marketing and Corporate Strategy, explained, “The development of the Engagement Suite exemplifies the continued innovation at PHT to improve the patient experience during a clinical trial. PHT is adding more services and capabilities trial sponsors are requesting to make it easier and more convenient for patients to participate in studies.”
About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Facebook, Twitter, Google+ and YouTube.